Repetitive Transcranial Magnetic Stimulation for Tobacco Treatment in Cancer Patients: A Preliminary Report of a One-Week Treatment

Xingbao Li, Benjamin A Toll, Matthew J Carpenter, Paul J Nietert, Morgan Dancy, Mark S George, Xingbao Li, Benjamin A Toll, Matthew J Carpenter, Paul J Nietert, Morgan Dancy, Mark S George

Abstract

Background: Smoking cessation represents a significant opportunity to improve cancer survival rates, reduces the risk of cancer treatment complications, and improves quality of life. However, about half of cancer patients who smoke continue to smoke despite the availability of several treatments. Previous studies demonstrate that repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) decreases cue craving, reduces cigarette consumption, and increases the quit rate in tobacco use disorder. We investigated whether 5 sessions of rTMS can be safely and efficaciously used for smoking cessation in cancer patients.

Methods: We enrolled 11 treatment-seeking smokers with cancer (>5 cigarettes per day) in a randomized, double-blind, sham-controlled proof-of-concept study. Participants received 5 daily sessions of active 10 Hz rTMS of the left DLPFC (3000 pulses per session) or sham rTMS and were followed up for 1 month via phone assessments. Main outcomes included reductions in the number of smoked-cigarettes per day (primary) and craving (secondary). Adverse effects were reported daily by participants.

Results: Seven of 11 participants completed 5 sessions of rTMS over one week. Compared to sham treatment (n = 4), the active rTMS (n = 3) exhibited modest effects overtime on smoking (Cohen's f 2 effect size of 0.16) and large effects on cue craving (Cohen's f 2 = 0.40). No serious side effects related to rTMS were reported in the treatment.

Conclusions: Five sessions of daily rTMS over the left DLPFC might benefit cancer patients who smoke cigarettes. However, further evidence is needed to determine with more certainty its therapeutic effect and adverse effects for cancer patients who smoke cigarettes.

Conflict of interest statement

The other authors declare no conflicts of interest.

Copyright © 2022 Xingbao Li et al.

Figures

Figure 1
Figure 1
One-week rTMS reduces cigarette consumption and cue-craving in cancer patients. (a) rTMS reduced CPD to a significantly greater degree than sham rTMS (p < 0.005) (sham: blue; active: red). Post hoc, there is a difference between the two treatments at 2nd visit, ∗p < 0.05. (b) rTMS reduced cue-craving to a significantly greater degree than sham rTMS (p < 0.0001) (sham: blue; active: red; presession measure: solid; postsession measure: dashes).

References

    1. Paul C. L., Tzelepis F., Boyes A. W., D'Este C., Sherwood E., Girgis A. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. Journal of Cancer Survivorship . 2019;13(5):687–694. doi: 10.1007/s11764-019-00787-5.
    1. Berg C. J., Thomas A. N., Mertens A. C., et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-Oncology . 2013;22(4):799–806. doi: 10.1002/pon.3077.
    1. Andreas S., Rittmeyer A., Hinterthaner M., Huber R. M. Smoking cessation in lung cancer-achievable and effective. Deutsches Ärzteblatt International . 2013;110(43):719–724. doi: 10.3238/arztebl.2013.0719.
    1. Ramaswamy A. T., Toll B. A., Chagpar A. B., Judson B. L. Smoking, cessation, and cessation counseling in patients with cancer: a population-based analysis. Cancer . 2016;122(8):1247–1253. doi: 10.1002/cncr.29851.
    1. Land S. R., Toll B. A., Moinpour C. M., et al. Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer research. Clinical Cancer Research . 2016;22(8):1907–1913. doi: 10.1158/1078-0432.CCR-16-0104.
    1. Balduyck B., Sardari Nia P., Cogen A., et al. The effect of smoking cessation on quality of life after lung cancer surgery. European Journal of Cardio-Thoracic Surgery . 2011;40(6):1432–1437. doi: 10.1016/j.ejcts.2011.03.004.
    1. General, Surgeon. US Department of Health and Human Services . CiteSeerX; 2014. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General.
    1. Park E. R., Perez G. K., Regan S., et al. Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. Journal of the American Medical Association . 2020;324(14):1406–1418. doi: 10.1001/jama.2020.14581.
    1. Shields P. G. B. NCCN clincal practice guidelines in oncology (NCCN guidelines) Smoking Cessation . 2019;Version 2
    1. Shields P. G., Herbst R. S., Arenberg D., et al. Smoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network . 2016;14(11):1430–1468.
    1. Leone F. T., Zhang Y., Evers-Casey S., et al. Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine . 2020;202(2):e5–e31. doi: 10.1164/rccm.202005-1982ST.
    1. George M. S., Lisanby S. H., Sackeim H. A. Transcranial magnetic Stimulation. Archives of General Psychiatry . 1999;56(4):300–311. doi: 10.1001/archpsyc.56.4.300.
    1. Brains way announces successful results in pivotal multicenter study evaluating deep transcranial magnetic stimulation system as an aid in smoking cessation. 2019. .
    1. Li X., Hartwell K. J., Henderson S., Badran B. W., Brady K. T., George M. S. Two weeks of image-guided left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation improves smoking cessation: a double-blind, sham-controlled, randomized clinical trial. Brain Stimulation . 2020;13(5):1271–1279. doi: 10.1016/j.brs.2020.06.007.
    1. Amiaz R., Levy D., Vainiger D., Grunhaus L., Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction . 2009;104(4):653–660. doi: 10.1111/j.1360-0443.2008.02448.x.
    1. Dinur-Klein L., Dannon P., Hadar A., et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biological Psychiatry . 2014;76(9):742–749. doi: 10.1016/j.biopsych.2014.05.020.
    1. Li X., Hartwell K. J., Owens M., et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biological Psychiatry . 2013;73(8):714–720. doi: 10.1016/j.biopsych.2013.01.003.
    1. Kraemer H. C. The Encyclopedia of Clinical Psychology . Hoboken, NJ, USA: John Wiley & Sons, Inc; 2014.
    1. Hartwell K. J., Johnson K. A., Li X., et al. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addiction Biology . 2011;16(4):654–666. doi: 10.1111/j.1369-1600.2011.00340.x.
    1. Ziemann U., Hallett M., Belmaker R. H. Basic neurophysiological studies with TMS. Transcranial Magnetic Stimulation in Neuropsychiatry . 2000;1:45–98.
    1. O'Reardon J. P., Solvason H. B., Janicak P. G., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological Psychiatry . 2007;62(11):1208–1216. doi: 10.1016/j.biopsych.2007.01.018.
    1. Arana A. B., Borckardt J. J., Ricci R., et al. Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimulation . 2008;1(1):44–51. doi: 10.1016/j.brs.2007.08.006.
    1. Borckardt J. J., Linder K. J., Ricci R., et al. Focal electrically administered therapy: device parameter effects on stimulus perception in humans. The Journal of ECT . 2009;25(2):91–98. doi: 10.1097/YCT.0b013e318183c6a4.
    1. Hughes J. R., Shiffman S., Naud S., Peters E. N. Day-to-day variability in self-reported cigarettes per day. Nicotine & Tobacco Research . 2017;19(9):1107–1111. doi: 10.1093/ntr/ntx057.
    1. Cox L. S., Tiffany S. T., Christen A. G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research . 2001;3(1):7–16. doi: 10.1080/14622200124218.
    1. Selya A. S., Rose J. S., Dierker L. C., Hedeker D., Mermelstein R. J. A practical guide to calculating Cohen's f (2), a measure of local effect size, from PROC MIXED. Frontiers in Psychology . 2012;3:p. 111. doi: 10.3389/fpsyg.2012.00111.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences . 2nd. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc; 1988.
    1. Baldassarri S. R., Toll B. A., Leone F. T. A comprehensive approach to tobacco dependence interventions. The Journal of Allergy and Clinical Immunology. In Practice . 2015;3(4):481–488. doi: 10.1016/j.jaip.2015.04.007.
    1. Toll B. A., Brandon T. H., Gritz E. R., Warren G. W., Herbst R. S. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clinical Cancer Research . 2013;19(8):1941–1948. doi: 10.1158/1078-0432.ccr-13-0666.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir